Showing 40 - 48 of 48
View by: Cover Page List Articles
-
An Acenocoumarol Dosing Algorithm Using Clinical and Pharmacogenetic Data in Spanish Patients with Thromboembolic Disease
published 20 Jul 2012
Loading metrics information...
Metrics unavailable. Please check back later.
-
Therapeutic Dosing of Acenocoumarol: Proposal of a Population Specific Pharmacogenetic Dosing Algorithm and Its Validation in North Indians
published 22 May 2012
Loading metrics information...
Metrics unavailable. Please check back later.
-
Pharmacogenetic Association of NOS3 Variants with Cardiovascular Disease in Patients with Hypertension: The GenHAT Study
published 28 Mar 2012
Loading metrics information...
Metrics unavailable. Please check back later.
-
Pharmacogenetic & Pharmacokinetic Biomarker for Efavirenz Based ARV and Rifampicin Based Anti-TB Drug Induced Liver Injury in TB-HIV Infected Patients
published 06 Dec 2011
Loading metrics information...
Metrics unavailable. Please check back later.
-
Pharmacogenetic Associations of MMP9 and MMP12 Variants with Cardiovascular Disease in Patients with Hypertension
published 24 Aug 2011
Loading metrics information...
Metrics unavailable. Please check back later.
-
Pharmacogenetic Modulation of Orexin Neurons Alters Sleep/Wakefulness States in Mice
published 27 May 2011
Loading metrics information...
Metrics unavailable. Please check back later.
-
VKORC1 Pharmacogenetics and Pharmacoproteomics in Patients on Warfarin Anticoagulant Therapy: Transthyretin Precursor as a Potential Biomarker
published 13 Dec 2010
Loading metrics information...
Metrics unavailable. Please check back later.
-
Flavopiridol Pharmacogenetics: Clinical and Functional Evidence for the Role of SLCO1B1/OATP1B1 in Flavopiridol Disposition
published 01 Nov 2010
Loading metrics information...
Metrics unavailable. Please check back later.
-
Fulfilling the Promise of Personalized Medicine? Systematic Review and Field Synopsis of Pharmacogenetic Studies
published 02 Dec 2009
Loading metrics information...
Metrics unavailable. Please check back later.
Connect with Us